The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,000.00 purchase order contract to Fudan University, a private university and non-profit organization, to provide support services for the PREDICT-TB study with Henan Chest Hospital and Fudan University in China. The contract is a firm fixed price arrangement with a completion date of July 17, 2019. The contract does not have a set-aside designation.
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Fudan University, a private university in China. The $75,000.00 Firm Fixed Price purchase order is for AMBIS 1919711 XPERT TESTING FOR THE PREDICT-TB PROJECT, with a performance location in China. The contract does not have a set-aside designation and was awarded on September 13, 2018 with a completion date of September 19, 2019. NIAID is the funding agency, and this...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $135,000.00 firm fixed price purchase order to Fudan University, a private university and non-profit educational institution, for the AMBIS 1866155 XPERT MTB/RIF TESTING PREDICT-TB PROJECT in Zhengzhou, Henan Province, China. The contract was awarded on September 21, 2017 with a completion date of September 21, 2018. The contract did not have a set-aside...
This federal contract award, with ID HHSN272201401219P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Fudan University. The contract, valued at $195,000.00, is for the provision of clinical research services and related reporting, including nursing services, coordination services, data services, laboratory services, medical services, supplies and equipment services, pharmaceutical services, and training services. The...
This is a $445,000.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Cape Town (UCT) in South Africa. The contract supports the PREDICT-TB and NEXGEN clinical trials, which are focused on tuberculosis research and development. UCT, a major research institution in South Africa, has extensive expertise in infectious disease research and...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the National Institute for Research in Tuberculosis, a non-profit hospital organization based in India. The $55,000 contract is for other unspecified functions and does not have a set-aside designation. Based on the awardee's past work as a subcontractor on tuberculosis research studies funded by NIH, this award is likely...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International Tuberculosis Research Center (ITRC) on August 14, 2014 for the "LTBI STUDY (2ND YEAR)" project. The contract has a ceiling value of $150,000.00 and a completion date of August 14, 2014. The contract is not designated as a set-aside. Based on the project title, this contract appears to be part of NIAID's larger efforts related to the...
This is a purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the National Institute For Research In Tuberculosis, a non-profit organization that operates as a hospital. The $537,500.00 firm fixed price award is to provide support to conduct studies on tuberculosis in India. The contract has a performance period ending on May 31, 2019 and was awarded on November 30, 2015. No set-aside was used for this contract. The National...
This is a $138,000.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Cape Town (UCT) for XPERT MTB/RIF testing in the PREDICT-TB project. The contract does not have a set-aside designation. UCT, a private university in Cape Town, South Africa, has previously received federal prime and sub-contract awards to support research related to infectious...
The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order contract to the University of Cape Town (UCT) to provide Coordination and Laboratory Support Services for the PREDICT-TB and NEXGEN projects. The contract, valued at $150,000.00, does not have a set-aside designation and was awarded on July 27, 2018, with a completion date of July 26, 2019. UCT, a private university located in...